Catalyst Wire Dossier Catalyst Wire Dossier

Degludec

degludec · Novo Nordisk
Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for Degludec, covering 2021-02-24 to 2025-05-16. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Insulin Efsitora Alfa (LY3209590) Compared to Degludec in Adults With Type 2 Diabetes Who Are Starting Basal Insulin for the First Time [Phase 3]

See pricing